Wang Ke, Dong Shuang, Higazy Doaa, Jin Lijing, Zou Qingcui, Chen Haowei, Inayat Aakif, Hu Sheng, Cui Min
State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.
Front Oncol. 2021 Jun 16;11:691771. doi: 10.3389/fonc.2021.691771. eCollection 2021.
Cancer patients usually suffer from unfavorable prognosis, particularly with the occurrence of brain metastasis of lung cancer. The key incident of brain metastasis initiation is crossing of blood-brain barrier (BBB) by cancer cells. Although preventing brain metastasis is a principal goal of cancer therapy, the cellular mechanisms and molecular regulators controlling the transmigration of cancer cells into the brain are still not clearly illustrated. We analyzed the mRNA expression profiles of metastatic brain tissues and TNF-α treated cancer cells to understand the changes in adhesion molecule expression during the tumor phase. To imitate the tumor microenvironment, an model was developed and the low or high metastatic potential lung tumor cells (A549 or H358) were cultured with the human brain microvascular endothelial cells (hBMECs) under TNF-α treatment. The analysis of online database indicated an altered expression for adhesion molecules and enrichment of their associated signaling pathways. TNF-α treatment activated hBMECs up-regulating several adhesion molecules, including , , , and . Meanwhile, TNF-α induced an increased expression of adhesion molecule ligands such as and in both A549 and H358. Moreover, the expression of adhesion molecules and the ligands were also increased both in A549- or H358-hBMECs mixed culture system, which promoted tumor cells adhesion to endothelial cells. These results suggested that the enhanced interaction between tumor cells and brain microvascular endothelium might facilitate the incidence of metastatic brain tumors and further offer a better comprehension of brain metastasis prevention and treatment.
癌症患者通常预后不佳,尤其是发生肺癌脑转移时。脑转移起始的关键事件是癌细胞穿越血脑屏障(BBB)。尽管预防脑转移是癌症治疗的主要目标,但控制癌细胞向脑内迁移的细胞机制和分子调节因子仍未明确阐明。我们分析了转移性脑组织和经肿瘤坏死因子-α(TNF-α)处理后的癌细胞的mRNA表达谱,以了解肿瘤阶段黏附分子表达的变化。为模拟肿瘤微环境,构建了一个模型,将低转移或高转移潜能的肺肿瘤细胞(A549或H358)与人脑微血管内皮细胞(hBMECs)在TNF-α处理下共同培养。在线数据库分析表明黏附分子表达改变及其相关信号通路富集。TNF-α处理激活hBMECs,上调包括[此处原文缺失具体分子名称]、[此处原文缺失具体分子名称]、[此处原文缺失具体分子名称]和[此处原文缺失具体分子名称]等多种黏附分子。同时,TNF-α诱导A549和H358中黏附分子配体如[此处原文缺失具体分子名称]和[此处原文缺失具体分子名称]的表达增加。此外,在A549-或H358-hBMECs混合培养体系中,黏附分子及其配体的表达也增加,这促进了肿瘤细胞与内皮细胞的黏附。这些结果表明,肿瘤细胞与脑微血管内皮之间增强的相互作用可能促进转移性脑肿瘤的发生,并进一步有助于更好地理解脑转移的预防和治疗。